2,6-diaminopurine has been researched along with Congenital Zika Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Costantino, G; Crespan, E; Kaptein, SJF; Maga, G; Neyts, J; Radi, M; Rivera, JIA; Vincetti, P | 1 |
1 other study(ies) available for 2,6-diaminopurine and Congenital Zika Syndrome
| Article | Year |
|---|---|
Identification of Broad-Spectrum Dengue/Zika Virus Replication Inhibitors by Functionalization of Quinoline and 2,6-Diaminopurine Scaffolds.
Topics: 2-Aminopurine; Antiviral Agents; Coinfection; Dengue; Dengue Virus; Drug Design; Drug Discovery; Humans; Models, Molecular; Quinolines; Virus Replication; Zika Virus; Zika Virus Infection | 2018 |